Nasdaq:US$14.79 (+0.03) | HKEX:HK$23.42 (+0.20) | AIM:£2.21 (-0.06)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn’s Disease Trial for HMPL-004 Delivers Encouraging Results

1 items
a090713